Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2022

Jul 12, 2022

SELL
$6.38 - $18.33 $638 - $1,832
-100 Closed
0 $0
Q1 2022

Apr 25, 2022

BUY
$12.38 - $19.1 $1,238 - $1,910
100 New
100 $1,000
Q2 2020

Jul 10, 2020

SELL
$27.21 - $41.0 $4,217 - $6,355
-155 Closed
0 $0
Q1 2020

Apr 09, 2020

BUY
$19.54 - $38.85 $3,028 - $6,021
155 New
155 $4,000

Others Institutions Holding IOVA

About IOVANCE BIOTHERAPEUTICS, INC.


  • Ticker IOVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 157,800,992
  • Market Cap $1.74B
  • Description
  • Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...
More about IOVA
Track This Portfolio

Track Fny Investment Advisers, LLC Portfolio

Follow Fny Investment Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fny Investment Advisers, LLC with notifications on news.